{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T14:04:56Z","timestamp":1697724296944},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1982,1,1]],"date-time":"1982-01-01T00:00:00Z","timestamp":378691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1982]]},"DOI":"10.1007\/bf00613608","type":"journal-article","created":{"date-parts":[[2004,11,25]],"date-time":"2004-11-25T11:50:06Z","timestamp":1101383406000},"page":"289-296","source":"Crossref","is-referenced-by-count":6,"title":["Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension"],"prefix":"10.1007","volume":"23","author":[{"given":"M. G.","family":"Bianchetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Boehringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Weidmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Link","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Schiffl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. H.","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.CIR.45.3.571","volume":"45","author":"TB Gottlieb","year":"1972","unstructured":"Gottlieb TB, Katz FH, Chidsey CA (1972) Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. Circulation 45: 571?582","journal-title":"Circulation"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM197203232861201","volume":"286","author":"R Zacest","year":"1972","unstructured":"Zacest R, Gilmore E, Koch-Weser J (1972) Treatment of essential hypertension with combined vasodilatation and beta-adrenergic-blockade. N Engl J Med 286: 617?622","journal-title":"N Engl J Med"},{"key":"CR3","first-page":"433s","volume":"57","author":"EM Taylor","year":"1979","unstructured":"Taylor EM, Roe AM, Slater RA (1979) SK & F 92657, a novel antihypertensive agent acting by pre-capillary vasodilatation and ?-adrenoceptor blockade. Clin Sci Mol Med 57: 433s-436s","journal-title":"Clin Sci Mol Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00005344-198103000-00013","volume":"3","author":"EM Taylor","year":"1981","unstructured":"Taylor EM, Eden RJ, Fielden R, Owen DAA (1981) Studies on the autonomic nervous system with SK & F 92657, a new antihypertensive agent causing direct arterial vasodilatation and ?-adrenoceptor-blockade. J Cardiovasc Pharmacol 3: 355?368","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005344-198103000-00012","volume":"3","author":"EM Taylor","year":"1981","unstructured":"Taylor EM, Cameron D, Eden RJ, Fielden R, Owen DAA (1981) Haemodynamic profile of a new antihypertensive agent D, L-3-(2-(3-t-Butylamino-2-hydroxypropoxy) phenyl)-6-hydrazinopyridazine) (SK & F 92657). J Cardiovasc Pharmacol 3: 337?354","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2125.1980.tb00512.x","volume":"10","author":"JW Collier","year":"1980","unstructured":"Collier JW, Pitcher DW (1980) Effects of SK & F 92657 on the superficial hand veins and forearm arterioles of man. Br J Clin Pharmacol 10: 567?571","journal-title":"Br J Clin Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"300P","DOI":"10.1111\/j.1365-2125.1980.tb04858.x","volume":"9","author":"DW Pitcher","year":"1980","unstructured":"Pitcher DW, Curry PVL, Trounce JR (1980) An assessment of ?-adrenoceptor-blockade in man by SK & F 92657, a new drug with combined vasodilator and B-adrenoceptor-blocking actions, and comparison with propranolol. Br J Clin Pharmacol 9: 300P-301P","journal-title":"Br J Clin Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/clpt.1981.82","volume":"29","author":"R Larsson","year":"1981","unstructured":"Larsson R, Karlberg BE, Norlander B, Wirs\u00e9n A (1981) Prizidilol, an antihypertensive with pre-capillary vasodilator and ?-adrenoceptor-blocking actions in primary hypertension. Clin Pharmacol Ther 29: 588?593","journal-title":"Clin Pharmacol Ther"},{"key":"CR9","first-page":"461s","volume":"59","author":"G Leonetti","year":"1980","unstructured":"Leonetti G, Terzoli L, Sala C, Bianchini C, Zanchetti A (1980) Dose response curve and time course of the antihypertensive effect of SK & F 92657, a ?-receptor-blocking and vasodilating agent compound. Clin Sci Mol Med 59: 461s-463s","journal-title":"Clin Sci Mol Med"},{"key":"CR10","first-page":"465s","volume":"61","author":"R Fariello","year":"1981","unstructured":"Fariello R, Alicandri CL, Agabiti Rosei E, Romanelli G, Castellano M, Beschi M, Platto L, Leto Di Piriolo S, Muiesan G (1981) Effects of prizidilol (SK & F 92657) on blood pressure, haemodynamics, sympathetic nervous system activity and plasma volume in essential hypertension. Clin Sci Mol Med 61: 465s-468s","journal-title":"Clin Sci Mol Med"},{"key":"CR11","first-page":"461s","volume":"61","author":"BE Karlberg","year":"1981","unstructured":"Karlberg BE, Larsson R, Ohman KP (1981) Prizidilol (SK & F 92657) in primary hypertension. Clin Sci Mol Med 61: 461s-464s","journal-title":"Clin Sci Mol Med"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/bmj.3.5825.506","volume":"3","author":"H Schr\u00f6der","year":"1972","unstructured":"Schr\u00f6der H (1972) Simplified method for determining acetylator phenotype. Br Med J 3: 506?507","journal-title":"Br Med J"},{"key":"CR13","first-page":"1146A","volume":"62","author":"WK Kirkendall","year":"1980","unstructured":"Kirkendall WK, Feinleib M, Freis ED, Mark AL (1980) Recommandations for human blood pressure determination by sphygmomanometers. Circulation 62: 1146A-1155A","journal-title":"Circulation"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ki.1972.34","volume":"1","author":"JE Sealey","year":"1972","unstructured":"Sealey JE, Gerten-Banes J, Laragh JH (1972) The renin system: variations in man measured by radioimmunoassay or bioassay. Kidney Int 1: 240?253","journal-title":"Kidney Int"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1530\/acta.0.0740558","volume":"74","author":"W Vetter","year":"1973","unstructured":"Vetter W, Vetter H, Siegenthaler W (1973) Radioimmunoassay for aldosterone without chromatography: II. Determination of plasma aldosterone. Acta Endocrinol 74: 558?567","journal-title":"Acta Endocrinol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1748-1716.1958.tb01627.x","volume":"44","author":"A Bertler","year":"1958","unstructured":"Bertler A, Carlsson A, Rosengren E (1958) A method for the fluorimetric determination of adrenaline and noradrenaline in tissue. Acta Physiol Scand 44: 273?292","journal-title":"Acta Physiol Scand"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/0024-3205(76)90251-4","volume":"19","author":"M Prada Da","year":"1976","unstructured":"Da Prada M, Z\u00fcrcher G (1976) Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci 19: 1161?1174","journal-title":"Life Sci"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ki.1978.171","volume":"14","author":"P Weidmann","year":"1978","unstructured":"Weidmann P, Beretta-Piccoli C, Ziegler WH, Keusch G, Gl\u00fcck Z, Reubi FC (1978) Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: Studies in normal subjects and patients with essential hypertension. Kidney Int 14: 619?628","journal-title":"Kidney Int"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00544594","volume":"20","author":"M Grimm","year":"1981","unstructured":"Grimm M, Weidmann P, Meier A, Ziegler WH, Reubi FC (1981) Acute effects of a new vasodilator, Ro 12-4713, on blood pressure, plasma renin activity, aldosterone and catecholamine levels, and renal function in hypertensive and normal subjects. Eur J Clin Pharmacol 20: 169?177","journal-title":"Eur J Clin Pharmacol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.RES.47.1.1","volume":"47","author":"S Wallenstein","year":"1980","unstructured":"Wallenstein S, Zucker CL, Fleiss JL (1980) Some statistical methods useful in circulation research. Circ Res 47: 1?9","journal-title":"Circ Res"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02289823","volume":"24","author":"SW Greenhouse","year":"1954","unstructured":"Greenhouse SW, Geisser S (1954) On methods in the analysis of profile data. Psychometrika 24: 95?112","journal-title":"Psychometrika"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00544592","volume":"20","author":"EM Soto","year":"1981","unstructured":"Soto EM, Thibonnier M, Sire O, Menard J, Corvol P, Milliez P (1981) Antihypertensive and hormonal effects of single oral doses of captopril and nifedipine in essential hypertension. Eur J Clin Pharmacol 20: 157?161","journal-title":"Eur J Clin Pharmacol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cpt1972133420","volume":"13","author":"R Zacest","year":"1972","unstructured":"Zacest R, Koch-Weser J (1972) Relation of hydralazine plasma concentration to dosage and hypotensive action. Clin Pharmacol Ther 13: 420?425","journal-title":"Clin Pharmacol Ther"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/cpt1973146970","volume":"14","author":"MM Reidenberg","year":"1973","unstructured":"Reidenberg MM, Drayer D, De Marco AL, Bello CT (1973) Hydralazine elimination in man. Clin Pharmacol Ther 14: 970?977","journal-title":"Clin Pharmacol Ther"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.0954-6820.1975.tb04922.x","volume":"197","author":"AJ Jounela","year":"1975","unstructured":"Jounela AJ, Pasanen M, Mattila MJ (1975) Acetylator phenotype and the antihypertensive response to hydralazine. Acta Med Scand 197: 303?306","journal-title":"Acta Med Scand"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00558327","volume":"10","author":"T Talseth","year":"1976","unstructured":"Talseth T (1976) Studies on hydralazine. 1. Serum concentrations of hydralazine in man after a single dose and at steady state. Eur J Clin Pharmacol 10: 183?186","journal-title":"Eur J Clin Pharmacol"},{"key":"CR27","unstructured":"Boehringer K, Bianchetti M, Weidmann P, Link L, Schiffl H, Beretta-Piccoli C, Reubi FC (1982) Acute cardiovascular, endocrine and renal effects of prizidilol. Proceedings 9th Int Soc Hypertension, Mexico-City, 21?24 Feb, N 48"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0002-9343(73)90134-4","volume":"55","author":"JO Davis","year":"1973","unstructured":"Davis JO (1973) The control of renin release. Am J Med 55: 333?350","journal-title":"Am J Med"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2125.1981.tb01267.x","volume":"12","author":"JA Steiner","year":"1981","unstructured":"Steiner JA, Clancy A, Manghani KK, James JM (1981) Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with ?-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers. Br J Clin Pharmacol 12: 573?578","journal-title":"Br J Clin Pharmacol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1172\/JCI105571","volume":"46","author":"Y Kaneko","year":"1967","unstructured":"Kaneko Y, Ikeda T, Takeda T, Ueda H (1967) Renin release during acute reduction of arterial pressure in normotensive subjects and patients with renovascular hypertension. J Clin Invest 46: 705?716","journal-title":"J Clin Invest"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/248531a0","volume":"284","author":"MH Irving","year":"1974","unstructured":"Irving MH, Britton BJ, Wood WG, Padgham C, Carruthers M (1974) Effects of ?-adrenergic blockade on plasma catecholamines in exercise. Nature 284: 531?533","journal-title":"Nature"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00613608.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00613608\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00613608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T23:42:45Z","timestamp":1554421365000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00613608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1982]]}},"alternative-id":["BF00613608"],"URL":"https:\/\/doi.org\/10.1007\/bf00613608","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982]]}}}